Estradiol, Progesterone, Immunomodulation, and COVID-19 Outcomes

Severe outcomes and death from the novel coronavirus disease 2019 (COVID-19) appear to be characterized by an exaggerated immune response with hypercytokinemia leading to inflammatory infiltration of the lungs and acute respiratory distress syndrome. Risk of severe COVID-19 outcomes is consistently...

Descripción completa

Detalles Bibliográficos
Autores principales: Mauvais-Jarvis, Franck, Klein, Sabra L, Levin, Ellis R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Mini-Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438701/
https://www.ncbi.nlm.nih.gov/pubmed/32730568
http://dx.doi.org/10.1210/endocr/bqaa127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438701/
https://www.ncbi.nlm.nih.gov/pubmed/32730568
http://dx.doi.org/10.1210/endocr/bqaa127

Ejemplares similares